Combination of microfluidic technology and blood flow research may help understand cardiovascular diseases

NewsGuard 100/100 Score

Announcing a new publication for BIO Integration journal. In this article the authors Meng Zhang, Wu Zhang, Zihuang Wang and Weiqian Chen from Sun Yat-Sen University, Guangzhou, China, Harvard University, Cambridge, MA, USA and Guangzhou University, Guangzhou, China review viscoelastic flow mixing in microfluidics.

The study of blood flow in vessels is crucial to understand cardiovascular diseases such as arrhythmias, coronary artery disease and deep vein thrombosis. In this paper a viscoelastic fluid in a microchannel is modelled to study blood flow.

The authors found that viscoelastic fluid has a transiently unstable flow pattern compared to the normal Newtonian fluid, and mixing is increased due to its elastic property. The integration of microfluidic technology with blood flow research could provide a new approach to understanding related disease mechanisms, and to analyze drug mixing and delivery in blood flow.

Source:
Journal reference:

Meng, Z., et al. (2020) Experimental Study On The Viscoelastic Flow Mixing In Microfluidics. BIO Integration. doi.org/10.15212/bioi-2020-0029.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer